OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Can Old Animals Reveal New Targets? The Aging and Degenerating Brain as a New Precision Medicine Opportunity for Epilepsy
Aarón del Pozo, Leanne M Lehmann, Kevin M. Knox, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 8
Aarón del Pozo, Leanne M Lehmann, Kevin M. Knox, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 8
Showing 8 citing articles:
Epilepsy: Mitochondrial connections to the ‘Sacred’ disease
Walter H. Moos, Douglas V. Faller, Ioannis P. Glavas, et al.
Mitochondrion (2023) Vol. 72, pp. 84-101
Open Access | Times Cited: 16
Walter H. Moos, Douglas V. Faller, Ioannis P. Glavas, et al.
Mitochondrion (2023) Vol. 72, pp. 84-101
Open Access | Times Cited: 16
Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence
Francesca Bosco, Lorenza Guarnieri, Vincenzo Rania, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12639-12639
Open Access | Times Cited: 9
Francesca Bosco, Lorenza Guarnieri, Vincenzo Rania, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12639-12639
Open Access | Times Cited: 9
Innovative drug discovery strategies in epilepsy: integrating next-generation syndrome-specific mouse models to address pharmacoresistance and epileptogenesis
Melissa Barker‐Haliski, Nicole A. Hawkins
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1099-1113
Closed Access | Times Cited: 3
Melissa Barker‐Haliski, Nicole A. Hawkins
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1099-1113
Closed Access | Times Cited: 3
Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discovery
Aarón del Pozo, Melissa Barker‐Haliski
Experimental Neurology (2022) Vol. 360, pp. 114288-114288
Open Access | Times Cited: 13
Aarón del Pozo, Melissa Barker‐Haliski
Experimental Neurology (2022) Vol. 360, pp. 114288-114288
Open Access | Times Cited: 13
Prevalence and localization of nocturnal epileptiform discharges in mild cognitive impairment
Rosario Ciliento, Klevest Gjini, Kevin Dabbs, et al.
Brain Communications (2023) Vol. 5, Iss. 6
Open Access | Times Cited: 7
Rosario Ciliento, Klevest Gjini, Kevin Dabbs, et al.
Brain Communications (2023) Vol. 5, Iss. 6
Open Access | Times Cited: 7
Prophylactic senolytic treatment in aged mice reduces seizure severity and improves survival from Status Epilepticus
Tahiyana Khan, Abbas I. Hussain, Timothy P. Casilli, et al.
Aging Cell (2024) Vol. 23, Iss. 9
Open Access | Times Cited: 2
Tahiyana Khan, Abbas I. Hussain, Timothy P. Casilli, et al.
Aging Cell (2024) Vol. 23, Iss. 9
Open Access | Times Cited: 2
Loss of normal Alzheimer's disease-associated Presenilin 2 function alters antiseizure medicine potency and tolerability in the 6-Hz focal seizure model
Leanne M Lehmann, Melissa Barker‐Haliski
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 3
Leanne M Lehmann, Melissa Barker‐Haliski
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 3
Alzheimer's disease-associated genotypes differentially influence chronic evoked seizure outcomes and antiseizure medicine activity in aged mice
Kevin M. Knox, Stephanie Davidson, Leanne M Lehmann, et al.
(2024)
Open Access
Kevin M. Knox, Stephanie Davidson, Leanne M Lehmann, et al.
(2024)
Open Access
